Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready
Next Life Sciences Inc. currently manages 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are concentrated within a single distinct art unit, showing a focused technical scope for the company's current intellectual property. The company is working with a sole distinct examiner for both of these pending matters, which allows for a more uniform prosecution strategy across the portfolio.
IGEL JR, MARK ALAN is the busiest examiner, responsible for 2 pending office actions. Since the busiest examiner pending count represents the entirety of the company's pending workload, the prosecution strategy can be highly specialized. This allows the company to focus its efforts on the specific requirements and examination style of this one individual within the Medical Devices & Mechanical Engineering field. By addressing the concerns of this single examiner, the company can efficiently advance its entire pending portfolio toward potential allowance.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| IGEL JR, MARK ALAN | 2 | 66.5% | +28.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19067591 | APPARATUS AND METHOD FOR DELIVERY AND/OR REMOVAL OF OCCLUSIONS IN THE BODY | IGEL JR, MARK ALAN | — |
| 18936754 | APPARATUS AND METHOD FOR DELIVERY AND/OR REMOVAL OF OCCLUSIONS IN THE BODY | IGEL JR, MARK ALAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19067591 | APPARATUS AND METHOD FOR DELIVERY AND/OR REMOVAL OF OCCLUSIONS IN THE BODY | IGEL JR, MARK ALAN | — |
| 18936754 | APPARATUS AND METHOD FOR DELIVERY AND/OR REMOVAL OF OCCLUSIONS IN THE BODY | IGEL JR, MARK ALAN | — |
| Art Unit | Apps |
|---|---|
| 3783 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19067591 | APPARATUS AND METHOD FOR DELIVERY AND/OR REMOVAL OF OCCLUSIONS IN THE BODY | IGEL JR, MARK ALAN | 3783 | §102§103§112 | Non-Final OA | — | Pending | Feb 28, 2025 |
| 18936754 | APPARATUS AND METHOD FOR DELIVERY AND/OR REMOVAL OF OCCLUSIONS IN THE BODY | IGEL JR, MARK ALAN | 3783 | §103§112 | Final Rejection | — | Pending | Nov 04, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNext Life Sciences Inc. has 2 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Mark Alan Igel Jr. has the most, with 2 of Next Life Sciences Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
